Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aldo Profumo

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Oncoimmunology|April 14, 2017
Zoledronate can induce colorectal cancer microenvironment expressing BTN3A1 to stimulate effector γδ T cells with antitumor activityMaria Raffaella Zocchi, Delfina Costa, Roberta Venè, et al.
British Journal of Pharmacology|May 1, 2021
Blocking glutamate mGlu<sub>5</sub> receptors with the negative allosteric modulator CTEP improves disease course in SOD1<sup>G93A</sup> mouse model of amyotrophic lateral sclerosisMarco Milanese, Tiziana Bonifacino, Carola Torazza, et al.
International Journal of Cancer|August 6, 2014
Pharmacokinetics, pharmacodynamics and efficacy on pediatric tumors of the glioma radiosensitizer KU60019Donatella Vecchio, Antonio Daga, Elisa Carra, et al.
Scientific Reports|March 1, 2019
Author Correction: Faithful animal modelling of human glioma by using primary initiating cells and its implications for radiosensitization therapyGuido Frosina, Jean Louis Ravetti, Renzo Corvò, et al.
Scientific Reports|September 23, 2018
Faithful animal modelling of human glioma by using primary initiating cells and its implications for radiosensitization therapy [ARRIVE 1]Guido Frosina, Jean Louis Ravetti, Renzo Corvò, et al.
Redox Biology|March 2, 2025
A multi-omics approach reveals impaired lipid metabolism and oxidative stress in a zebrafish model of Alexander diseaseDeianira Bellitto, Matteo Bozzo, Silvia Ravera, et al.
Cancers|July 27, 2022
A Circulating Risk Score, Based on Combined Expression of Exo-miR-130a-3p and Fibrinopeptide A, as Predictive Biomarker of Relapse in Resectable Non-Small Cell Lung Cancer PatientsSilvia Marconi, Michela Croce, Giovanna Chiorino, et al.
Frontiers in Pharmacology|January 18, 2024
Fraisinib: a calixpyrrole derivative reducing A549 cell-derived NSCLC tumor <i>in vivo</i> acts as a ligand of the glycine-tRNA synthase, a new molecular target in oncologyIméne Ben Toumia, Tiziana Bachetti, Leila Chekir-Ghedira, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Oncoimmunology|April 14, 2017
Zoledronate can induce colorectal cancer microenvironment expressing BTN3A1 to stimulate effector γδ T cells with antitumor activityMaria Raffaella Zocchi, Delfina Costa, Roberta Venè, et al.
British Journal of Pharmacology|May 1, 2021
Blocking glutamate mGlu<sub>5</sub> receptors with the negative allosteric modulator CTEP improves disease course in SOD1<sup>G93A</sup> mouse model of amyotrophic lateral sclerosisMarco Milanese, Tiziana Bonifacino, Carola Torazza, et al.
International Journal of Cancer|August 6, 2014
Pharmacokinetics, pharmacodynamics and efficacy on pediatric tumors of the glioma radiosensitizer KU60019Donatella Vecchio, Antonio Daga, Elisa Carra, et al.
Scientific Reports|March 1, 2019
Author Correction: Faithful animal modelling of human glioma by using primary initiating cells and its implications for radiosensitization therapyGuido Frosina, Jean Louis Ravetti, Renzo Corvò, et al.
Scientific Reports|September 23, 2018
Faithful animal modelling of human glioma by using primary initiating cells and its implications for radiosensitization therapy [ARRIVE 1]Guido Frosina, Jean Louis Ravetti, Renzo Corvò, et al.
Redox Biology|March 2, 2025
A multi-omics approach reveals impaired lipid metabolism and oxidative stress in a zebrafish model of Alexander diseaseDeianira Bellitto, Matteo Bozzo, Silvia Ravera, et al.
Cancers|July 27, 2022
A Circulating Risk Score, Based on Combined Expression of Exo-miR-130a-3p and Fibrinopeptide A, as Predictive Biomarker of Relapse in Resectable Non-Small Cell Lung Cancer PatientsSilvia Marconi, Michela Croce, Giovanna Chiorino, et al.
Frontiers in Pharmacology|January 18, 2024
Fraisinib: a calixpyrrole derivative reducing A549 cell-derived NSCLC tumor <i>in vivo</i> acts as a ligand of the glycine-tRNA synthase, a new molecular target in oncologyIméne Ben Toumia, Tiziana Bachetti, Leila Chekir-Ghedira, et al.
Pageof 4